{"SPADE_UN_11760": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11760", "Peptide Name": "[G1K, L5Y, K8R]cGm (Derived from Gm)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "KCRRYCYRQRCVTYCRGR", "Sequence Length": 18, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Antifungal", "Antitumor"], "Target Organism": "[Ref.28741926]Gram-positive bacteria :Staphylococcuss aureus ATCC 25923 (MIC=8 μM);Gram-negative bacteria :Escherichia coli ATCC 25922 (MIC=0.5-1 μM), Klebsiella pneumoniae ATCC 700603 (MIC=4-8 μM), Acinetobacter baumannii ATCC 19606 (MIC=1-2 μM), Pseudomonas aeruginosa ATCC 27853 (MIC<0.25-0.5 μM);Fungi :Candida albicans ATCC 90028 (MIC=4 μM), Cryptococcus neoformans ATCC 208821 (MIC=0.5 μM)", "Hemolytic Activity": "[Ref.28741926] 20.6-32% hemolysis at 64 μM against human red blood cells", "Cytotoxicity": "[Ref.28741926] CC50 = 26.5 ± 2.4 μM against CRL-1739, CC50 = 2.0 ± 0.1 μM against MM96L, CC50 = 14.7 ± 1.5 μM against HFF-1, CC50 = 20.9 ± 1.4 μM against HeLa, CC50 = 15.2 ± 1.9 μM against MCF-7, CC50 = 1.3 ± 0.1 μM against K-562, CC50 = 15.7 ±1.1μM against HL-60;CC50=10.4 ± 1.0μM against PBMCs.", "Binding Target": "Not found", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "No specific N-terminal", "C-terminal Modification": "No specific C-terminal", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C97H160N38O24S4", "Mass": 2370.81, "PI": 10.1, "Net Charge": 7, "Hydrophobicity": -1.4, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria, Antifungal activity agaist Candida albicans, Cryptococcus neoformans", "Literature": [{"Title": "Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties", "Pubmed ID": "28741926", "Reference": "ACS Chem Biol. 2017 Sep 15;12(9)2324-2334. doi 10.1021/acschembio.7b00459.?", "Author": "Sonia Troeira Henriques, Nicole Lawrence, Stephanie Chaousis, Anjaneya S. Ravipati, Olivier Cheneval,Aurelie H. Benfield, Alysha G. Elliott, Angela Maria Kavanagh, Matthew A. Cooper, Lai Yue Chan,Yen-Hua Huang, and David J. Craik", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28741926"}], "Frequent Amino Acids": "RCY", "Absent Amino Acids": "ADEFHILMNOPSUW", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 4, "Polar Residues": 17, "Positive Residues": 7, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_00870", "Similarity": 1.0, "Sequence": "WCFVCRGCRKCRR"}, {"SPADE_ID": "SPADE_UN_11756", "Similarity": 0.9444444444444444, "Sequence": "KCRRLCYRQRCVTYCRGR"}, {"SPADE_ID": "SPADE_N_03758", "Similarity": 0.9411764705882353, "Sequence": "CRRYCYKQRCVTYCRGR"}]}}}